Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Weaning IV Vasopressors in Septic Shock
NCT03911817Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of midodrine in septic shock (2 arms), sponsored by Ain Shams University. Primary endpoint: Time of weaning of IV vasopressor in both groups at 30 days. Started Nov 2017; status: completed.
02
Drugs
midodrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03911817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03911817.